TIA1 antibody (AA 279-380)

Catalog No. ABIN7873218

The Mouse Monoclonal anti-TIA1 antibody is suitable to detect TIA1 in samples from Human. It has been validated for WB and IF.

Quick Overview for TIA1 antibody (AA 279-380) (ABIN7873218)

Target: TIA1 (TIA1 Cytotoxic Granule-Associated RNA Binding Protein (TIA1))

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This TIA1 antibody is un-conjugated

Application: Western Blotting (WB), Immunofluorescence (IF)

Grade: Carrier-free

Clone: TIA1-1313

Product Details anti-TIA1 Antibody

Binding Specificity: AA 279-380

Purpose: TIA1 Antibody (azide and preservative free)

Purification: Protein G affinity chromatography

Immunogen: Amino acids 279-380 from the human protein were used as the immunogen for the TIA1 antibody.

Isotype: IgG2b, kappa

Application Details

Application Notes: Optimal dilution of the TIA1 antibody should be determined by the researcher.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 1 mg/mL in 1X PBS, BSA free, sodium azide free

Preservative: Azide free

Storage: 4 °C,-20 °C

Storage Comment: Store the TIA1 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).

Target Details for TIA1

Target: TIA1 (TIA1 Cytotoxic Granule-Associated RNA Binding Protein (TIA1))

Alternative Name: TIA1

Background: TIA-1 (T-cell intracytoplasmic antigen) is a cytoplasmic granule-associated protein, expressed in lymphocytes processing cytolytic potential. TIA-1 is a member of an RNA-binding protein family and possesses nucleolytic activity against cytotoxic lymphocyte (CTL) target cells. It has been suggested that this protein may be involved in the induction of apoptosis as it preferentially recognizes poly(A) homopolymers and induces DNA fragmentation in CTL targets. The major granule-associated species is a 15 kDa protein thought to be derived from the carboxyl terminus of the 40 kDa product by proteolytic processing. TIA1 antibody labels cytotoxic T cells and natural killer cells (NK cells). It is also expressed in T-cell lymphoma, large granular lymphocyte (LGL) leukemia and hairy cell leukemia. TIA1 expression in T-cell malignancies may help in differentiating LGL leukemia (high expression) from T-cell lymphocytosis and other T-cell diseases (low expression). TIA1 may also be used to label tumor-infiltrating lymphocytes in the study of immune response to malignancies.

UniProt: P31483